<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Prinaberel</id>
	<title>Prinaberel - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Prinaberel"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Prinaberel&amp;action=history"/>
	<updated>2026-04-12T07:20:01Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Prinaberel&amp;diff=49932&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Prinaberel&amp;diff=49932&amp;oldid=prev"/>
		<updated>2025-03-18T10:33:18Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:33時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49931:rev-49932 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Prinaberel&amp;diff=49931&amp;oldid=prev</id>
		<title>bsd&gt;Ffffrr: Importing Wikidata short description: &quot;Chemical compound&quot; (Shortdesc helper)</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Prinaberel&amp;diff=49931&amp;oldid=prev"/>
		<updated>2022-04-23T09:38:21Z</updated>

		<summary type="html">&lt;p&gt;Importing Wikidata &lt;a href=&quot;http://en.wikipedia.org/wiki/Short_description&quot; class=&quot;extiw&quot; title=&quot;wikipedia:Short description&quot;&gt;short description&lt;/a&gt;: &amp;quot;Chemical compound&amp;quot; (&lt;a href=&quot;http://en.wikipedia.org/wiki/Shortdesc_helper&quot; class=&quot;extiw&quot; title=&quot;wikipedia:Shortdesc helper&quot;&gt;Shortdesc helper&lt;/a&gt;)&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| IUPAC_name               = (4&amp;#039;&amp;#039;Z&amp;#039;&amp;#039;)-2-Fluoro-4-(5-hydroxy-7-vinyl-1,3-benzoxazol-2(3&amp;#039;&amp;#039;H&amp;#039;&amp;#039;)-ylidene)-2,5-cyclohexadien-1-one&lt;br /&gt;
| image                    = Prinaberel.svg&lt;br /&gt;
| width                    = 250&lt;br /&gt;
| CAS_number               = 524684-52-4&lt;br /&gt;
| CAS_supplemental         = &lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = A9C8MNF7CA&lt;br /&gt;
| ATC_prefix               = None&lt;br /&gt;
| ATC_suffix               = &lt;br /&gt;
| PubChem                  = 5326893&lt;br /&gt;
| ChemSpiderID             = 4484184&lt;br /&gt;
| C=15 | H=10 | F=1 | N=1 | O=3&lt;br /&gt;
| smiles                   = O=C3\C=C/C(=C2/Oc1c(cc(O)cc1N2)\C=C)/C=C3/F&lt;br /&gt;
| StdInChI                 = 1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,17-18H,1H2/b15-9-&lt;br /&gt;
| StdInChIKey              = FCXYSEXZEGPLGG-DHDCSXOGSA-N&lt;br /&gt;
| bioavailability          = &lt;br /&gt;
| protein_bound            = &lt;br /&gt;
| metabolism               = &lt;br /&gt;
| elimination_half-life    = &lt;br /&gt;
| excretion                = &lt;br /&gt;
| pregnancy_category       = &lt;br /&gt;
| legal_status             = &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Prinaberel&amp;#039;&amp;#039;&amp;#039; ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) (developmental code names &amp;#039;&amp;#039;&amp;#039;ERB-041&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;&amp;#039;WAY-202041&amp;#039;&amp;#039;&amp;#039;) is a [[synthetic compound|synthetic]], [[nonsteroidal]], and highly [[binding selectivity|selective]] [[agonist]] of the [[estrogen receptor beta|ERβ]] [[isoform|subtype]] of the [[estrogen receptor]].&amp;lt;ref name=&amp;quot;pmid14500559&amp;quot;&amp;gt;{{cite journal  |vauthors=Harris HA, Albert LM, Leathurby Y, etal | title = Evaluation of an estrogen receptor-beta agonist in animal models of human disease | journal = Endocrinology | volume = 144 | issue = 10 | pages = 4241–9 |date=October 2003 | pmid = 14500559 | doi = 10.1210/en.2003-0550 | url = http://endo.endojournals.org/cgi/pmidlookup?view=long&amp;amp;pmid=14500559| doi-access = free }}&amp;lt;/ref&amp;gt; It is used in [[scientific research]] to elucidate the role of the ERβ receptor.&amp;lt;ref name=&amp;quot;pmid15857973&amp;quot;&amp;gt;{{cite journal |vauthors=Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA | title = Reflections on the discovery and significance of estrogen receptor beta | journal = Endocrine Reviews | volume = 26 | issue = 3 | pages = 465–78 |date=May 2005 | pmid = 15857973 | doi = 10.1210/er.2004-0027 | url = http://edrv.endojournals.org/cgi/pmidlookup?view=long&amp;amp;pmid=15857973| doi-access = free }}&amp;lt;/ref&amp;gt; Studies have indicated that selective ERβ agonists like prinaberel could be useful in the clinical treatment of a variety of [[medical condition]]s including [[inflammatory bowel disease]], [[rheumatoid arthritis]], [[endometriosis]], and [[sepsis]].&amp;lt;ref name=&amp;quot;pmid17824176&amp;quot;&amp;gt;{{cite journal | author = Harris HA | title = Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential | journal = Ernst Schering Foundation Symposium Proceedings | volume = 2006/1| issue = 1 | pages = 149–61 | year = 2006 | pmid = 17824176 | doi = 10.1007/2789_2006_021| isbn = 978-3-540-49547-5 }}&amp;lt;/ref&amp;gt; Accordingly, prinaberel either was or still is under investigation by [[Wyeth]] for the treatment of some of these conditions.&amp;lt;ref name=&amp;quot;Wyeth2006&amp;quot;&amp;gt;{{cite web | url = http://business.highbeam.com/436989/article-1G1-146524305/prinaberel-wyeth-phase-change-ii-usa | archive-url = https://web.archive.org/web/20160307162827/https://business.highbeam.com/436989/article-1G1-146524305/prinaberel-wyeth-phase-change-ii-usa | url-status = dead | archive-date = 2016-03-07 | title = Prinaberel - Wyeth phase change II, USA (endometriosis) | date = 2006-06-05 | work = R &amp;amp; D Focus Drug News | access-date = 2012-05-20}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[Diarylpropionitrile]]&lt;br /&gt;
* [[ERB-196]]&lt;br /&gt;
* [[Erteberel]]&lt;br /&gt;
* [[WAY-200070]]&lt;br /&gt;
* [[WAY-214156]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
* [http://adisinsight.springer.com/drugs/800020667 Prinaberel - AdisInsight]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Benzoxazoles]]&lt;br /&gt;
[[Category:Fluoroarenes]]&lt;br /&gt;
[[Category:Selective ERβ agonists]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{genito-urinary-drug-stub}}&lt;/div&gt;</summary>
		<author><name>bsd&gt;Ffffrr</name></author>
	</entry>
</feed>